PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC12839123::ACT034829

L-CR5

Evidence text

Paper-level observation

L-CR5 showed expression levels of 99–100% in the 25–100 μg/mL range, had little tendency to decrease, and no significant inhibitory effect was observed at 100.80% even at 200 and 400 μg/mL.
textConfidence: medium

Assay observation

Activity
Antioxidant
Subtype
MMP-1 Inhibitor
Measure
percent_inhibition
Comparator
~
Raw observation
99–100% expression (no inhibition) at 25–100 μg/mL; 100.80% expression at 200–400 μg/mL
Normalized measurement
~0%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
CCD-986sk
Assay method
Not reported by source
Sequence
CYGSR
Standardization
ready simple

Source publication

Comparison of In Vitro Multiple Physiological Activities of Cys–Tyr–Gly–Ser–Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking

Biomolecules · 2026

DOI 10.3390/biom16010126 PMC12839123
Parent mention

Related peptide identities

PEPDIA-PLP-000379

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.